Gérard Pons

8.9k total citations · 1 hit paper
200 papers, 6.5k citations indexed

About

Gérard Pons is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Gérard Pons has authored 200 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 78 papers in Pediatrics, Perinatology and Child Health, 37 papers in Psychiatry and Mental health and 36 papers in Pharmacology. Recurrent topics in Gérard Pons's work include Pharmaceutical studies and practices (41 papers), Epilepsy research and treatment (36 papers) and Pharmacological Effects and Toxicity Studies (33 papers). Gérard Pons is often cited by papers focused on Pharmaceutical studies and practices (41 papers), Epilepsy research and treatment (36 papers) and Pharmacological Effects and Toxicity Studies (33 papers). Gérard Pons collaborates with scholars based in France, Netherlands and United Kingdom. Gérard Pons's co-authors include Elisabeth Rey, Jean‐Marc Tréluyer, Vincent Jullien, Catherine Chiron, Olivier Dulac, Sergi Ganau, Robert Martí, Jean‐Louis Vincent, P D’Athis and Melcior Sentís and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Gérard Pons

191 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Automated Breast Ultrasound Lesions Detection Using Convolutional Neural Networks

2017 680 citations Gérard Pons et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gérard Pons France	45	2.4k	1.5k	853	762	670	200	6.5k
Nicholas H. G. Holford New Zealand	59	3.3k 1.4×	727 0.5×	3.0k 3.5×	1.2k 1.5×	1.8k 2.7×	210	12.9k
Stuart L. Beal United States	30	978 0.4×	400 0.3×	1.4k 1.6×	895 1.2×	726 1.1×	52	6.6k
Greet Van den Berghe Belgium	91	2.4k 1.0×	941 0.6×	422 0.5×	856 1.1×	180 0.3×	645	42.0k
E. Niclas Jonsson Sweden	37	825 0.3×	399 0.3×	974 1.1×	933 1.2×	762 1.1×	90	6.1k
Magnus Borga Sweden	40	703 0.3×	442 0.3×	667 0.8×	548 0.7×	412 0.6×	188	6.1k
Danny D. Shen United States	56	3.3k 1.4×	983 0.6×	1.2k 1.4×	3.0k 3.9×	3.7k 5.6×	223	12.1k
Angela Yee‐Moon Wang China	55	831 0.4×	321 0.2×	358 0.4×	366 0.5×	124 0.2×	265	15.1k
Richard Baumgartner United States	68	1.3k 0.5×	2.1k 1.3×	623 0.7×	4.1k 5.3×	75 0.1×	278	24.8k
J. David Spence Canada	72	852 0.4×	731 0.5×	1.0k 1.2×	1.1k 1.5×	1.7k 2.5×	413	21.7k
Andrew Bate United Kingdom	34	804 0.3×	439 0.3×	1.1k 1.3×	539 0.7×	428 0.6×	122	6.2k

Countries citing papers authored by Gérard Pons

Since Specialization

Citations

This map shows the geographic impact of Gérard Pons's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gérard Pons with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gérard Pons more than expected).

Fields of papers citing papers by Gérard Pons

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gérard Pons. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gérard Pons. The network helps show where Gérard Pons may publish in the future.

Co-authorship network of co-authors of Gérard Pons

This figure shows the co-authorship network connecting the top 25 collaborators of Gérard Pons. A scholar is included among the top collaborators of Gérard Pons based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gérard Pons. Gérard Pons is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Marlow, Neil, Keith J. Barrington, Jan Miletín, et al.. (2025). Outcomes of extremely preterm infants who participated in a randomised trial of dopamine for treatment of hypotension (the HIP trial) at 2 years corrected age. Archives of Disease in Childhood Fetal & Neonatal. 110(6). 542–547. 1 indexed citations

Dempsey, Eugene, Keith J. Barrington, Neil Marlow, et al.. (2021). Hypotension in Preterm Infants (HIP) randomised trial. Archives of Disease in Childhood Fetal & Neonatal. 106(4). 398–403. 46 indexed citations

Dempsey, Eugene, Keith J. Barrington, Neil Marlow, et al.. (2014). Management of Hypotension in Preterm Infants (The HIP Trial): A Randomised Controlled Trial of Hypotension Management in Extremely Low Gestational Age Newborns. Neonatology. 105(4). 275–281. 47 indexed citations

Chhun, Stéphanie, Vincent Jullien, Elisabeth Rey, et al.. (2009). Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy. Epilepsia. 50(5). 1150–1157. 48 indexed citations

Chhun, Stéphanie, Elisabeth Rey, Agnès Tran, et al.. (2007). Simultaneous quantification of voriconazole and posaconazole in human plasma by high-performance liquid chromatography with ultra-violet detection. Journal of Chromatography B. 852(1-2). 223–228. 81 indexed citations

Goldwirt, Lauriane, Stéphanie Chhun, Elisabeth Rey, et al.. (2007). Quantification of darunavir (TMC114) in human plasma by high-performance liquid chromatography with ultra-violet detection. Journal of Chromatography B. 857(2). 327–331. 40 indexed citations

Alexandre, J., Elisabeth Rey, V. Girre, et al.. (2006). Relationship between cytochrome 3A activity, inflammatory status and the risk of docetaxel-induced febrile neutropenia: a prospective study. Annals of Oncology. 18(1). 168–172. 51 indexed citations

Jacqz-Aigrain, Évelyne, Véronique Lamarque, E. Autret‐Leca, et al.. (2006). Méthodes de surveillance et de gestion des risques des médicaments pour la future mère, l’embryon, le fœtus et le nouveau-né. Therapies. 61(4). 287–295. 2 indexed citations

Chappuy, Hélène, Jean‐Marc Tréluyer, Elisabeth Rey, et al.. (2004). Maternal-fetal transfer and amniotic fluid accumulation of protease inhibitors in pregnant women who are infected with human immunodeficiency virus. American Journal of Obstetrics and Gynecology. 191(2). 558–562. 42 indexed citations

10.

Rey, Elisabeth, Christine Bulteau, Jacques Motté, et al.. (2004). Oxcarbazepine Pharmacokinetics and Tolerability in Children With Inadequately Controlled Epilepsy. The Journal of Clinical Pharmacology. 44(11). 1290–1300. 33 indexed citations

11.

Jullien, Vincent, Jean‐Marc Tréluyer, Gérard Pons, & Elisabeth Rey. (2003). Determination of tenofovir in human plasma by high-performance liquid chromatography with spectrofluorimetric detection. Journal of Chromatography B. 785(2). 377–381. 60 indexed citations

12.

Pons, Gérard, et al.. (2000). [How to improve drug development and utilization in pediatrics].. PubMed. 54(4). 423–32. 5 indexed citations

13.

Tréluyer, Jean‐Marc & Gérard Pons. (2000). Quoi de neuf en pharmacologie pédiatrique ?. Archives de Pédiatrie. 7(12). 1330–1338. 6 indexed citations

14.

Tran, Agnès, Elisabeth Rey, Gérard Pons, et al.. (1997). Influence of stiripentol on cytochrome P450-mediated metabolic pathways in humans: In vitro and in vivo comparison and calculation of in vivo inhibition constants*. Clinical Pharmacology & Therapeutics. 62(5). 490–504. 89 indexed citations

15.

Pariente‐Khayat, Ann, Elisabeth Rey, D Gendrel, et al.. (1997). Isoniazid acetylation metabolic ratio during maturation in children. Clinical Pharmacology & Therapeutics. 62(4). 377–383. 41 indexed citations

16.

Roy, Robert Le, F De Larrard, & Gérard Pons. (1996). EXTENSION DU DOMAINE D'APPLICATION DES REGLEMENTS DE CALCUL BAEL/BPEL AUX BETONS A 80 MPa - JUSTIFICATIONS SCIENTIFIQUES DES PROPOSITIONS AVANCEES - CALCUL DES DEFORMATIONS INSTANTANEES ET DIFFEREES DES BETONS A HAUTES PERFORMANCES. 1 indexed citations

17.

Bertin, L., Gérard Pons, P D’Athis, et al.. (1996). A randomized, double‐blind, multicentre controlled trial of ibuprofen versus acetaminophen and placebo for symptoms of acute otitis media in children. Fundamental and Clinical Pharmacology. 10(4). 387–392. 81 indexed citations

18.

Pons, Gérard, et al.. (1992). RETRAIT ET FLUAGE DE BETONS A HAUTES PERFORMANCES : DONNEES POUR LE CALCUL DES DEFORMATIONS DIFFEREES. 3 indexed citations

19.

Bertin, L., Elisabeth Rey, Gérard Pons, et al.. (1991). Pharmacokinetics of tiaprofenic acid in children after a single oral dose. European Journal of Clinical Pharmacology. 41(3). 251–253. 6 indexed citations

20.

Pons, Gérard, Bernard L. Mirkin, & Robert M. O’Dea. (1981). Biological characterization of murine neuroblastoma: in vivo neurogenic tumor model. Abstr.. The Mouseion at the JAXlibrary (Jackson Laboratory). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact